There are frequent media headlines about both the scarcity of machine learning talent and about the promises of companies claiming their products automate machine learning and eliminate the need for ML expertise altogether. In his keynote at the TensorFlow DevSummit, Google’s head of AI Jeff Dean estimated that there are tens of millions of organizations that have electronic data that could be used for machine learning but lack the necessary expertise and skills. I follow these issues closely since my work at fast.ai focuses on enabling more people to use machine learning and on making it easier to use.
“Together we create the European World-Class leader in digital payments,” said Grapinet in a statement. “I am convinced that the combination of our respective remarkable talents [SIC] pools, joint capabilities and state-of-the art offers will procure our combined Company an outstanding value proposition to pursue an exceptional growth benefitting to all our clients, banks and merchants alike and to all our business partners. This is a landmark transaction for the industrial consolidation of European payments, highly value creative for all our stakeholders and for the shareholders of both companies, and which ambitions to reinforce the role of Europe within the global digital payment ecosystem.”
Disney+ launched on November 12 and is not yet available globally. The day after the launch, the company said the service already had more than 10 million subscribers.
Cisco is one of the few technology companies that led an industry defining role 30 years ago and continues to be a market leader today. In the 90s, Cisco built the internet, and today we are shaping the future of the digital enterprise. The ability for one company to remain relevant, navigate and lead through all these market opportunities and transitions is simply amazing and is due in large part to our unique approach to innovation. Cisco has a culture of leveraging both internal and external innovation – accelerating our rich internal development capabilities by our ability to also partner, invest and acquire. In essence, Cisco has always recognized that there is significant innovation that happens outside of the walls of Cisco, and we have chosen to embrace this capability to its fullest. Over our history, Cisco has acquired over 200 companies and more than one in eight Cisco employees have joined as a result. We have a deep bench of acquired founders, many of which play leadership roles within the company today, which continues to re-inforce this entrepreneurial spirit.
But GeForce Now isn’t a free service. Customers basically rent a gaming PC in a data center near them. Right now, it costs $5 per month to access the Founders edition, which lets you play whenever you want and for as long as you want. But the company says that it plans to raise the subscription fee at some point.
However, further development of CRISP-DM seems to have stalled, with only a 1.0 version fully produced almost two decades ago, and rumors of a second version under way almost fifteen years ago. IBM and Microsoft have both iterated on the methodologies to produce their own variants that add more detail with respect to more iterative loops between data processing and modeling and more specifics around artifacts and deliverables produced during the process. However, both companies are primarily leveraging their modifications in the context of delivering their own premium service engagements or as part of product-centric implementation processes. Clearly vendor-centric, proprietary methodologies can’t be adopted by organizations that have diverse technology needs or desire to utilize vendor-agnostic approaches to technology implementation.
Business growth strategies rely on new revenue streams, which necessitate new and agile pricing models that can adapt to changing market needs. Thanks to the web, consumers are demanding more pay-as-you-go and fee-based products and services, and businesses are necessarily adapting internal business processes to accommodate agile pricing strategies. Without the ability to pivot pricing strategies rapidly, companies will not be able to optimize or will miss out on new revenue opportunities.
Antler is a “company builder” that emerged a couple of years ago, running startup generator programs and investing from an early stage, bringing a heady mix of technologists, product builders and operators together with its own technology stack.
There is a major change ahead for LinkedIn, the social network for the working world, now with 675 million members. Jeff Weiner, who has been leading the company as CEO for the past 11 years, is stepping down on June 1, 2020. His new role will be executive chairman. Ryan Roslansky, who is currently head of product, will be stepping up to the role of CEO, while Tomer Cohen, who had been under Roslansky, is stepping up to lead the product team.
But the company remains a bit of a rollercoaster when it comes to financials. Twitter’s forecast for next quarter is looking like it might be another challenging one in terms of margins and overall sales. Twitter’s forecasting revenue to be between $825 million and $885 million and operating income to be between $0 million and $30 million.
It’s inherently stressful: you’re running out of capital, which is why you’re trying to get more of it. There’s also no clear roadmap to getting funding and almost every company goes through the process differently. I’ve talked a lot about what makes a successful early-stage pitch deck and what you can expect when you’re trying to close a funding round. But do those same best practices still apply when you’re fundraising outside of the United States?
Carta is a fun company because the more problems we solve, the more problems we get to solve. Today we have more problems to solve than bandwidth to solve them. But we still want these problems to be solved.
Wall says his company knows most of the owners in the elite streets. "There are only 14 homes in Cremorne Street and we've sold nine of them, some of them twice," he says. "Owners call us and ask what price they might get for the house. We tell them what we think, and they tell us to go for it. So we get on the phone and make a dozen calls, and within a week it's sold."
Full terms of the deal remain as yet unknown, although a Companies House update reveals that Facebook Inc. now has majority control of the company (more than 75%). However by looking at other filings, including a recent share issue, I understand the price could be about $40 million.
Snowflake, the cloud-based data warehouse company, doesn’t tend to do small rounds. On Friday night word leaked out about its latest mega round. This one was for $479 million on a $12.4 billion valuation. That’s triple the company’s previous $3.9 billion valuation from October 2018, and CEO Frank Slootman suggested that the company’s next finance event is likely an IPO.
One might imagine that Musk, who has always spoken his mind, has been emboldened of late thanks to the skyrocketing value of Tesla of late. But Musk has long been a critic of Facebook, tweeting in 2018 after deleting his companies’ Facebook pages that he doesn’t “like Facebook. Gives me the willies. Sorry.”
The law, California’s Consumer Privacy Act — or CCPA — became law on January 1, allowing state residents to reclaim their right to access and control their personal data. Inspired by Europe’s GDPR, the CCPA is the largest statewide privacy law change in a generation. The new law lets users request a copy of the data that tech companies have on them, delete the data when they no longer want a company to have it, and demand that their data isn’t sold to third parties. All of this is much to the chagrin of the tech giants, some of which had spent millions to comply with the law and have many more millions set aside to deal with the anticipated influx of consumer data access requests.
To date, the SEC has brought enforcement actions against a number of companies that created and sold tokens, including Telegram and Kik, two major messaging platforms.
The back-of-the-envelope math offers a revealing glimpse into the storied tech company’s current thinking on blockchain. Cuomo’s revenue figure comes as IBM works to bring enterprise blockchain closer into the company’s sprawling cloud offering. Some commentators have described the move as a reprioritization or even consolidation following the dissipating hype surrounding distributed ledger technology (DLT).
But just five years later, Chainalysis is now the cryptocurrency-tracing equivalent of Palantir, the data analytics company flush with lucrative government software contracts. Chainalysis is, right now, doing millions of dollars worth of business each year with the U.S. government, dwarfing its competitors in the young industry of blockchain surveillance.
At the U.S. Chamber of Commerce later in the afternoon, during an event sponsored by Uber and other companies, Mr. Kenyatta said the agreement “will not only serve Kenya and the United States but will probably set the base for renewed engagement between the United States and other African countries.”
Eli Lilly and Company (NYSE:LLY) offers an attractive opportunity for shareholders in 2020. The more than 140-year-old drug company has a few compelling metrics that demonstrate significant value for investors, including a strong return on equity (ROE), a modest dividend payout ratio, and continued profitability when compared with peers including GlaxoSmithKline (NYSE:GSK) and Pfizer (NYSE:PFE).
Epizyme, Inc. (Nasdaq: EPZM), a biopharmaceutical company developing novel epigenetic therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of TAZVERIK™ (tazemetostat) for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection, based on overall response rate and duration of response in a Phase 2 clinical trial.
LabCFTC, the U.S. Commodity Futures Trading Commission's (CFTC) financial technology experimentation branch, is holding office hours on April 1, asking local companies to ask questions, discuss issues or present their projects.
"Current information now indicates this rate of growth will not be achieved," the company said in a statement.
The emerging dominance of e-commerce creates an opportunity to co-ordinate approaches between China and New Zealand and ensure a smooth flow of commerce and access for our companies and consumers. Clear rules to support e-commerce means every single New Zealander can share in the benefits of Chinese trade.
Health data management company Seqster said this week that it has received a strategic investment of undisclosed size from Takeda Pharmaceuticals of Japan. Seqster, a software-as-a-service firm based in San Diego, plans to use the new funds to accelerate the adoption of its interoperability technology for enhancing clinical trials, patient engagement, and outcomes.
GenMark Diagnostics has appointed Scott Mendel, its chief operating officer, as interim president and CEO, effective immediately. Hany Massarany has stepped down as president and CEO and as a member of the company’s board of directors, also effective immediately. GenMark said it has commenced a search to identify a permanent CEO.
Roland Diggelmann has been appointed to Accelerate Diagnostics' board of directors. Diggelmann is currently CEO of Smith+Nephew, a British medical equipment manufacturing company, having recently succeeded Namal Nawana, the former CEO of Alere. Diggelmann previously served as CEO of Roche Diagnostics, and also worked in the orthopedics sector at Sulzer Orthopedics and Zimmer Group.
Abbott announced Miles White will be stepping down as CEO on March 31, 2020 after 21 years in the position, and will be replaced by Robert Ford. Ford has been the president and COO of Abbott since October 2018, and was appointed to the board. Before that, Ford was the executive VP of medical devices at the company, and has been at Abbott since 1996. Miles will remain executive chairman of BD's board.
Guardant Health has appointed Kumud Kalia as its new chief information officer. In the role, he will lead the company's enterprise applications, information technology, and security teams. Kalia was most recently chief information and technology officer at Cylance, and previously served the same role at Akamai Technologies. He received Computerworld's "best in class" recognition among its 100 premier information technology leaders and has led teams that have won CIO100, CTO25, and other industry awards. He holds an honors degree in electronic engineering from Bangor University, is a chartered engineer, and is a fellow of both the Institution of Engineering and Technology and the British Computer Society.
A pair of companies in San Francisco’s SOMA neighborhood and Tel Aviv are positioning themselves as the “Wintel” of the bio-hacking era. One company, called Genome Compiler, builds software for designing synthetic life forms, while the other, Cambrian Genomics, is experimenting with ways to cheaply laser print DNA.
Enter Synthace, the startup developing Antha, a language and software platform specifically for biology. In 2018, the company raised a £26 million series B round led by Horizons Ventures, to continue to develop their cloud software platform. With clients and partners such as Microsoft, Merck, Oxford Biomedica, LabGenius and Princeton, the company is fast becoming the pioneer in so-called "Computer-Aided Biology."
“There are other companies and hospitals working on ways to interpret the genome. However, no one that we are aware of is working on better ways to deliver and distribute the content necessary to make these interpretations happen. We’re the only ones focusing on making the jobs of developers easier in this field,” SolveBio’s CEO and co-founder Mark Kaganovich said in an email.
DNA sequencing was still very expensive and rare at the time, but Mangubat and her cofounders at Spiral Genetics anticipated a day when the cost of sequencing a genome would drop enough to allow scientists to sequence hundreds of thousands or millions of human genomes, whole populations, and compare them to learn about disease. To analyze such a volume of data, with the technology of the time, would have been prohibitively difficult and time-consuming, Mangubat predicted. Her company aimed to leverage cloud-based computing to crunch those huge gene sets, taking a fraction of the time.
Genome editing software company Desktop Genetics and Imperial College London's cancer epigenetics unit have received a £300,000 ($430,000) grant from Innovate UK, which they will use to develop software tools that selectively design CRISPR/Cas9 targets against cancer cell lines that are characterized at the epigenetic level.
Like other companies in the field, TeselaGen gives its product away for free to academic researchers and then charges corporate clients annual subscription fees.
Portfolia launched the first ever Femtech focused investment fund in 2017, and has since invested in fertility company Future Family, vaginal health startup Madorra, genomics and diagnostics company Prime Genomics, which is developing a breakthrough approach to detect cancer, and the newest addition, Sana, an innovative device for pain management. Additionally, Portfolia has invested through others funds on menopause health platform Genneve and device company Joylux. Christina Jenkins, MD, is also an independent advisor to Elektra Health, a startup focusing on guiding women through menopause launching in 2020.
This is not to say that no startups are working to commercialize this technology. Last year, CureMetrix became the first company to receive FDA approval for its AI-based breast cancer technology; the company plans to deploy in several clinical settings this year. Other startups angling to commercialize and scale AI-based radiology in the near term include Arterys, Aidoc, Zebra Technologies and DeepHealth.
I spoke to Lev Grzhonko, CEO of MonDevices, to find out how their company garnered interest and presence with national retailers to grow the business and increase sales. MonDevices created the most affordable smart baby monitoring product on the market called MonBaby. Grzhonko shared the company’s top B2B strategies that support the efforts of its B2C resellers.
Heartland Group Holdings lifted first-half net profit 20.4 per cent, although that was boosted by accounting changes and fair value gains and the underlying increase was closer to 7 per cent. The company, which operates Heartland Bank in New Zealand and a reverse mortgage business in Australia, also increased its first-half dividend to 4.5 cents per share from 3.5 cents last year.
Danaher this week announced a regular quarterly cash dividend of $.18 per share of its common stock, payable on April 24 to shareholders of record on March 27. The company’s board of directors also approved a quarterly cash dividend of $11.785 per share of its 4.75 percent Series A Mandatory Convertible Preferred Stock, payable on April 15 to shareholders of record on March 31.
OnRamp Bioinformatics, Inc., a genomics company providing the premier scientist-focused data analysis platform, and Advaita BioInformatics, a leader in personalized medicine and interpretation of Next-Gen Sequencing data, announced they have partnered to provide a comprehensive research experience from sample to interpretation with a seamless hand-off between systems.
The first indicator of top-quartile transformation is the scope of the effort itself. Successful companies, our findings suggest, typically favor an all-in, enterprise-wide transformation, rather than constraining the transformation to individual business units or functions. A more comprehensive scope increases the chances of creating value-generating opportunities across functions. This was the case for the basic-materials company whose story is described in the sidebar “The power of scope: A case study.” It also proved effective for a consumer-goods company we know whose leaders designed a series of transformation processes to harvest the fruits of improved integration across the company’s supply-chain, manufacturing, and sales units.
S4 Agtech, which offers risk management solutions for agriculture companies, migrated to Google Cloud to save money and time, as well as, scale databases and machine learning models faster. The company uses BigQuery as its data warehouse, and has dramatically reduced storage and processing costs by 80%, while providing customers their analytics results 25% faster. S4 has also gained more time for innovation in helping its customers de-risk crop production, including updating and improving algorithms.
Nexletol works by inhibiting cholesterol production. It can reduce LDL cholesterol by 28% the company said. The company has also applied for FDA approval to use the drug as a combination pill with ezetimibe, another non-statin. In studies, that combination reduced cholesterol between 38% to 44%, the company said. That FDA decision is expected soon.
Esperion, which is based in Ann Arbor, Mich., said the drug’s brand name will be Nexletol. Esperion also has applied to the FDA for approval of a combination pill of bempedoic acid and ezetimibe, a non-statin pill approved in 2002. In studies, the combination pill reduced cholesterol by about 38 to 44 percent, depending on whether a person was taking a statin and how much, the company said. The FDA decision is expected shortly.
So Google is now part of Alphabet, a new holding company that will manage Google and all of its other products. Why is the new company called Alphabet? Google/Alphabet CEO Larry Page says it’s because Alphabet means a “collection of letters that represent language, one of humanity’s most important innovations, and is the core of how we index with Google search!” But the domain name for Alphabet is abc.xyz — not alphabet.com (which is currently getting hammered with traffic it seems).
Cofactor is a large, structured listing of people, places, and things. Here you can find the description of each topic.